A synthetic peptide for use as a blocking control in assays to test for specificity of AKAP5 antibody, Alternative Names: AKAP5 control peptide, AKAP5 antibody Blocking Peptide, Anti-AKAP5 Blocking Peptide, A-kinase anchoring protein 5 Blocking Peptide, Prka Anchor Protein 5 Blocking Peptide, AKAP Blocking Peptide, AKAP75 Blocking Peptide, AKAP79 Blocking Peptide, H21 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
AKAP5
(A Kinase (PRKA) Anchor Protein 5 (AKAP5))
Substanzklasse
Viral Protein
Hintergrund
The A-kinase anchor proteins (AKAPs) are a group of structurally diverse proteins, which have the common function of binding to the regulatory subunit of protein kinase A (PKA) and confining the holoenzyme to discrete locations within the cell. AKAP5 is a member of the AKAP family. It binds to the RII-beta regulatory subunit of PKA, and also to protein kinase C and the phosphatase calcineurin. It is predominantly expressed in cerebral cortex and may anchor the PKA protein at postsynaptic densities (PSD) and be involved in the regulation of postsynaptic events. It is also expressed in T lymphocytes and may function to inhibit interleukin-2 transcription by disrupting calcineurin-dependent dephosphorylation of NFAT.